Table 2.
Predictors | N | OR (95% Cl)a | P-value |
---|---|---|---|
Plasma IFN-γ | 81 | 1.71 (0.88, 3.33) | 0.12 |
Plasma CXCL10 | 99 | 13.4(1.23,145.52) | 0.021* |
Plasma IL-6 | 130 | 2.85 (1.37, 5.91) | 0.005** |
Plasma TNF-α | 127 | 1.90 (1.09,3.33) | 0.025* |
Plasma CCL2 | 100 | 0.45 (0.05, 4.25) | 0.49 |
Plasma CXCL8 | 142 | 1.82 (0.40, 8.19) | 0.44 |
CSF CXCL10 | 44 | 0.88 (0.16, 4.70) | 0.88 |
CSF IL-6 | 41 | 0.13 (0.001, 13.4) | 0.39 |
CSF TNF-α | 46 | 0.45 (0.04, 5.77) | 0.54 |
CSF CCL2 | 41 | 0.38 (0.004, 39.3) | 0.68 |
CSF CXCL8 | 56 | 0.32 (0.01, 8.61) | 0.50 |
Notes:
The odds ratio > 1 indicates higher odds of cognitive impairment, and the odds ratio < 1 indicates lower odds of cognitive impairment. For biomarkers, the odds ratio is measured per 1 unit increase on log10 scale. For sex, the odds ratio compares men to women (reference group). For HIV viral load, the odds ratio compares detectable to undetectable (reference group).
For the interaction, the provided estimate are a ratio of odds ratios.
P<0.05
P<0.01.
OR = odds ratio; CI = confidence interval.